Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.
Publication
, Journal Article
Salerno, SN; Burckart, GJ; Huang, S-M; Gonzalez, D
Published in: Clin Pharmacol Ther
May 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
May 2019
Volume
105
Issue
5
Start / End Page
1067 / 1070
Location
United States
Related Subject Headings
- Risk Assessment
- Pharmacology & Pharmacy
- Pharmacological Phenomena
- Pediatrics
- Observational Studies as Topic
- Medication Therapy Management
- Humans
- Drug Interactions
- Drug Development
- Drug Design
Citation
APA
Chicago
ICMJE
MLA
NLM
Salerno, S. N., Burckart, G. J., Huang, S.-M., & Gonzalez, D. (2019). Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clin Pharmacol Ther, 105(5), 1067–1070. https://doi.org/10.1002/cpt.1234
Salerno, Sara N., Gilbert J. Burckart, Shiew-Mei Huang, and Daniel Gonzalez. “Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.” Clin Pharmacol Ther 105, no. 5 (May 2019): 1067–70. https://doi.org/10.1002/cpt.1234.
Salerno SN, Burckart GJ, Huang S-M, Gonzalez D. Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clin Pharmacol Ther. 2019 May;105(5):1067–70.
Salerno, Sara N., et al. “Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.” Clin Pharmacol Ther, vol. 105, no. 5, May 2019, pp. 1067–70. Pubmed, doi:10.1002/cpt.1234.
Salerno SN, Burckart GJ, Huang S-M, Gonzalez D. Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clin Pharmacol Ther. 2019 May;105(5):1067–1070.
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
May 2019
Volume
105
Issue
5
Start / End Page
1067 / 1070
Location
United States
Related Subject Headings
- Risk Assessment
- Pharmacology & Pharmacy
- Pharmacological Phenomena
- Pediatrics
- Observational Studies as Topic
- Medication Therapy Management
- Humans
- Drug Interactions
- Drug Development
- Drug Design